|
|
||||||||
Signaling Pathway1

*
Department of Biochemistry and Molecular Biology, College of Medicine, and
Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612
Gene activation in early development is highly dependent on precise
concentrations of trans-acting factors for the
activation of different genes at differing points in the embryo. Thus,
not only is the presence or absence of a particular
trans-activator or repressor relevant in determining
gene activation, but also the concentration of the regulatory protein
must be above or below a certain threshold for proper gene regulation.
Signaling pathways in somatic cells are thought to represent cascades
of on/off switches, mediated most commonly by phosphorylation. Here we
demonstrate a quantitative mechanism for regulating the level of a
component of the IFN-
signaling pathway that in effect represents
the differential sensitivities of STAT1, IFN-regulatory factor-1, and
class II trans-activator (CIITA) to IFN-
. Unlike
developmental gene regulation, in which specificity of gene activation
is a function of regulatory protein concentrations, specificity of gene
activation in the IFN-
signaling pathway is regulated by the
duration of the activation of the primary IFN-
-regulatory protein,
STAT1. This result most likely explains previously reported data
indicating that a minimum amount of IFN-
is required for MHC class
II gene activation despite the fact that the level of the
IFN-
-inducible factor directly required for MHC class II induction,
CIITA, directly correlates with the level of MHC class II expression.
The induction of a high level of CIITA is dependent on sustained
IFN-
signaling. The possible implications of this result for
tumorigenesis are discussed.
This article has been cited by other articles:
![]() |
N. Chetoui, K. Sylla, J.-V. Gagnon-Houde, C. Alcaide-Loridan, D. Charron, R. Al-Daccak, and F. Aoudjit Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis Mol. Cancer Res., January 1, 2008; 6(1): 42 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Choi, R. Holtz, M. G. Petroff, N. Alfaidy, and S. P. Murphy Dampening of IFN-{gamma}-Inducible Gene Expression in Human Choriocarcinoma Cells Is Due to Phosphatase-Mediated Inhibition of the JAK/STAT-1 Pathway J. Immunol., February 1, 2007; 178(3): 1598 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Osborne, H. Zhang, G. Fejer, K. M. Palubin, M. I. Niesen, and G. Blanck Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells: AN Oct-1-CONTAINING REPRESSOSOME THAT PREVENTS NF-Y BINDING TO THE HLA-DRA PROMOTER J. Biol. Chem., July 9, 2004; 279(28): 28911 - 28919. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Muczynski, D. M. Ekle, D. M. Coder, and S. K. Anderson Normal Human Kidney HLA-DR-Expressing Renal Microvascular Endothelial Cells: Characterization, Isolation, and Regulation of MHC Class II Expression J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1336 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Pai, D. Askew, W. H. Boom, and C. V. Harding Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator J. Immunol., August 1, 2002; 169(3): 1326 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumatori, D. Yang, S. Suzuki, and M. Nakamura Cooperation of STAT-1 and IRF-1 in Interferon-gamma -induced Transcription of the gp91phox Gene J. Biol. Chem., March 8, 2002; 277(11): 9103 - 9111. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Osborne, H. Zhang, W.-M. Yang, E. Seto, and G. Blanck Histone Deacetylase Activity Represses Gamma Interferon-Inducible HLA-DR Gene Expression following the Establishment of a DNase I-Hypersensitive Chromatin Conformation Mol. Cell. Biol., October 1, 2001; 21(19): 6495 - 6506. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |